HYUNDAI FEED Inc Asset Resilience Ratio

Latest as of June 2025: 11.71%

HYUNDAI FEED Inc asset resilience ratio. HYUNDAI FEED Inc (016790) has an Asset Resilience Ratio of 11.71% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 016790 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩12.36 Billion
≈ $8.37 Million USD Cash + Short-term Investments

Total Assets

₩105.49 Billion
≈ $71.49 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio of HYUNDAI FEED Inc (2015–2024)

Asset resilience ratio of HYUNDAI FEED Inc from 2015 to 2024. This chart shows how HYUNDAI FEED Inc's Asset Resilience Ratio has changed over time. Read how much debt does HYUNDAI FEED Inc carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down HYUNDAI FEED Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 016790 current and non-current assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩12.36 Billion 11.71%
Total Liquid Assets ₩12.36 Billion 11.71%

Asset Resilience Insights

  • Moderate Liquidity: HYUNDAI FEED Inc has 11.71% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

HYUNDAI FEED Inc Industry Peers by Asset Resilience Ratio

Compare HYUNDAI FEED Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
The Magnum Ice Cream Company N.V.
AS:MICC
Packaged Foods 0.11%
Unibel S.A
PA:UNBL
Packaged Foods 0.24%
JiangXi Tianxin Pharm Co Ltd
SHG:603235
Packaged Foods 4.40%
Sanquan Food Co Ltd
SHE:002216
Packaged Foods 13.01%
JinJian Cereals Industry Co Ltd
SHG:600127
Packaged Foods 0.04%
Beijing Sanyuan Foods Co Ltd
SHG:600429
Packaged Foods 0.10%
Kri-Kri Milk Industry S.A
AT:KRI
Packaged Foods 1.34%
Ridley Corporation Ltd
AU:RIC
Packaged Foods 0.27%

HYUNDAI FEED Inc Asset Resilience Ratio by Year (2015–2024)

HYUNDAI FEED Inc asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for HYUNDAI FEED Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 9.40% ₩11.00 Billion
≈ $7.45 Million
₩116.98 Billion
≈ $79.28 Million
+8.94pp
2023-12-31 0.46% ₩500.00 Million
≈ $338.84K
₩108.36 Billion
≈ $73.43 Million
-2.08pp
2022-12-31 2.55% ₩6.91 Billion
≈ $4.68 Million
₩271.27 Billion
≈ $183.84 Million
-3.21pp
2021-12-31 5.75% ₩5.39 Billion
≈ $3.66 Million
₩93.77 Billion
≈ $63.55 Million
-8.57pp
2020-12-31 14.33% ₩14.07 Billion
≈ $9.53 Million
₩98.21 Billion
≈ $66.55 Million
+12.11pp
2019-12-31 2.21% ₩2.15 Billion
≈ $1.46 Million
₩97.38 Billion
≈ $65.99 Million
-6.09pp
2018-12-31 8.30% ₩7.81 Billion
≈ $5.29 Million
₩94.05 Billion
≈ $63.74 Million
-10.90pp
2017-12-31 19.20% ₩16.29 Billion
≈ $11.04 Million
₩84.84 Billion
≈ $57.49 Million
+5.98pp
2016-12-31 13.22% ₩10.95 Billion
≈ $7.42 Million
₩82.82 Billion
≈ $56.13 Million
+2.82pp
2015-12-31 10.40% ₩11.17 Billion
≈ $7.57 Million
₩107.39 Billion
≈ $72.78 Million
--
pp = percentage points

About HYUNDAI FEED Inc

KQ:016790 Korea Packaged Foods
Market Cap
$126.96 Million
₩187.34 Billion KRW
Market Cap Rank
#18126 Global
#788 in Korea
Share Price
₩994.00
Change (1 day)
+0.00%
52-Week Range
₩994.00 - ₩994.00
All Time High
₩15077.70
About

HYUNDAI FEED Inc. engages in the manufacture and sale of formulated feed. Its primary products include poultry and pig feed. The company also engages in the biopharmaceutical business. In addition, it focuses on the development and commercialization of immunotherapies for cancer. Further, the company's lead product includes oregovomab, an immunotherapy for ovarian cancer. Additionally, it is invo… Read more